Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Treatment commences in U.K. phase II study of clofarabine for adult AML

Aug. 12, 2004

Quadramet to be investigated in a novel trial in high-risk prostate cancer patients

Aug. 12, 2004

New U.K. phase I study investigates systemic administration of Reolysin

Aug. 12, 2004

New program evaluates Modrenal in pre- and postmenopausal women

Aug. 12, 2004

Novel antimitotic agent circumvents tumor resistance in vivo

Aug. 12, 2004

Human multidrug resistance protein 1 targeted in malignant cells

Aug. 11, 2004

New epothilone derivatives in early development at Novartis

Aug. 11, 2004

Japanese researchers prepare and test a new antineoplastic antibiotic

Aug. 11, 2004

New KDR and FGFR inhibitors with potential in solid tumor therapy

Aug. 11, 2004

Yakult Honsha and Taiho to copromote oxaliplatin in Japan

Aug. 11, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...